George Yancopoulos on Saturday discussed his company’s experimental antibody treatment, Regeneron, that was administered to U.S. President Donald Trump after he tested positive for COVID-19, saying it was “validating” to see Trump’s medical team decide to administer the drug.
- Regeneron’s COVID-19 drug cuts risk of death for hospitalized patients, study shows
- Regeneron: What we know about the experimental coronavirus drug Trump took
- Regeneron drugs in demand after Trump coronavirus treatment — but it’s not available to public